Trials / Terminated
TerminatedNCT02532036
MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection
A Phase I Trial to Compare the Safety and Immunogenicity of Candidate TB Vaccine MVA85A Administered by the Aerosol Inhaled Route and the Intramuscular Route in Healthy Adult Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
TB040 is a clinical trial to investigate and compare the effects of a candidate Tuberculosis (TB) vaccine, MVA85A, administered by the aerosol inhaled route and the intramuscular route in healthy adult volunteers who are latently infected with Mycobacterium tuberculosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Aerosol inhaled MVA85A | |
| BIOLOGICAL | Intramuscular MVA85A | |
| BIOLOGICAL | Intramuscular Saline placebo | |
| BIOLOGICAL | Aerosol inhaled Saline placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-10-04
- Completion
- 2018-10-04
- First posted
- 2015-08-25
- Last updated
- 2020-08-31
- Results posted
- 2020-08-31
Locations
5 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02532036. Inclusion in this directory is not an endorsement.